VT
WST icon

Vise Technologies’s West Pharmaceutical WST Stock Holding History

Vise Technologies’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$499K Buy
1,391
+557
+67% +$170K 0.01% 1157
2026
Q1 		$229K Hold
834
– – ﹤0.01% 1308
2025
Q4 		$229K Sell
834
-16
-2% -$4.38K ﹤0.01% 1318
2025
Q3 		$223K Buy
+850
New +$207K 0.01% 1069
2024
Q4 		$203K Buy
+619
New +$195K 0.02% 775

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Vise Technologies's WST Position: Q2 2026 in Review

Vise Technologies increased its West Pharmaceutical (WST) stake by 67% in Q2 2026, buying an estimated $170K and bringing the position to 1,391 shares worth $499K. The position accounts for 0.01% of the portfolio, ranked #1157.

Vise Technologies first reported a position in WST in Q4 2024 and has held it in 5 quarters since. 834 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Vise Technologies held 1,391 shares of West Pharmaceutical worth $499K as of Q2 2026.
  • Vise Technologies bought 557 West Pharmaceutical shares in Q2 2026, an estimated $170K.
  • West Pharmaceutical made up 0.01% of Vise Technologies's portfolio in Q2 2026, its #1157 holding.
  • Vise Technologies first reported a position in West Pharmaceutical in Q4 2024 and has held it in 5 quarters since.
  • 834 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Vise Technologies's 13F filing for Q2 2026, filed 11 Aug 2026.